Boston Scientific has acquired all remaining shares in its portfolio company Farapulse, having first invested in the University of Iowa spinout in 2014.

Farapulse, a US-based medical device developer spun out of University of Iowa, has been acquired by its peer and existing shareholder Boston Scientific for a $295m upfront payment.
Boston Scientific currently owns a 27% stake in the spinout and will purchase all remaining shares. The corporate may pay out an additional $92m in milestone payments, as well as an undisclosed amount of revenue-based payments over the next three years.
Founded in 2014 as Iowa Approach, Farapulse is working…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Thierry Heles

Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.